Adenosine A(2A) Agonist Improves Lung Function During Ex-vivo Lung Perfusion

BACKGROUND: Ex-vivo lung perfusion (EVLP) is a novel technique to assess, and potentially repair marginal lungs that may otherwise be rejected for transplantation. Adenosine has been shown to protect against lung ischemia-reperfusion injury through its A(2A) receptor. We hypothesized that combining...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emaminia, Abbas, LaPar, Damien J., Zhao, Yunge, Steidle, John F., Harris, David A., Linden, Joel, Kron, Irving L., Lau, Christine L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3259746/
https://ncbi.nlm.nih.gov/pubmed/22051279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2011.06.062
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares